Blood products part of FDA xenotransplant plan

被引：0

|

作者：

Jeffrey L. Fox

机构：

来源：

Nature Biotechnology | 2000年 / 18卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：258 / 258

相关论文

共 50 条

[31] Regulation of combination products by the FDA
Hellman, KB
Smith, D
GENETIC ENGINEERING NEWS, 2005, 25 (10): : 24 - +
[32] FDA STANDARDS FOR VANILLA PRODUCTS
不详
FOOD TECHNOLOGY, 1964, 18 (05) : 718 - &
[33] FDA'S STRATEGIC PLAN EMPHASIZES SCIENCE
不详
CHEMICAL & ENGINEERING NEWS, 2011, 89 (17) : 28 - 28
[34] PLAN FOR EXPANDED USE OF DIDEOXYINOSINE APPROVED BY FDA
不详
CLINICAL PHARMACY, 1989, 8 (12): : 827 - 827
[35] FDA defends generic drug labeling plan
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2014, 71 (10) : 770 - +
[36] FDA announces safety plan for erythropoiesis stimulants
Reactions Weekly, 2010, 1289 (1) : 2 - 2
[37] Plan B: Politics and values at the FDA, again
Dresser, R
HASTINGS CENTER REPORT, 2004, 34 (06) : 9 - 10
[38] FDA announces plan to halt marketing of terfenadine
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (04) : 342 - 342
[39] FDA approves Onsolis with risk reduction plan
Reactions Weekly, 2009, 1262 (1) : 2 - 2
[40] FDA presents its acrylamide action plan
Hileman, B
CHEMICAL & ENGINEERING NEWS, 2002, 80 (40) : 7 - 7

← 1 2 3 4 5 →